Detail Information of Epigenetic Regulations

General Information of Drug Transporter (DT)
DT ID DTD0035 Transporter Info
Gene Name SLC30A8
Transporter Name Zinc transporter 8
Gene ID
169026
UniProt ID
Q8IWU4
Epigenetic Regulations of This DT (EGR)

Methylation

  Type 2 diabetes

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Hypermethylation of SLC30A8 in type 2 diabetes [ 1 ]

Location

 Promoter

Epigenetic Type

 Methylation Experiment Method .

Related Molecular Changes

 Down regulation of SLC30A8 Experiment Method RT-qPCR

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Patient tissue samples

Additional Notes

 Epigenetic analysis showed that DNA methylation levels in the SLC30A8 gene are increased in type 2 diabetes patients.

  Epigenetic Phenomenon 2

 Hypermethylation of SLC30A8 in type 2 diabetes [ 1 ]

Location

 Promoter

Epigenetic Type

 Methylation Experiment Method .

Related Molecular Changes

 Down regulation of SLC30A8 Experiment Method Western Blot

Studied Phenotype

 Type 2 diabetes [ ICD-11: 5A11]

Experimental Material

 Patient tissue samples

Additional Notes

 Epigenetic analysis showed that DNA methylation levels in the SLC30A8 gene are increased in type 2 diabetes patients.

  Prostate cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in prostate cancer [ 2 ]

Location

 5'UTR (cg00612138)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.91E+00 Statistic Test p-value: 7.76E-03; Z-score: 4.16E+00

Methylation in Case

 1.15E-01 (Median) Methylation in Control 6.02E-02 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in prostate cancer [ 2 ]

Location

 TSS1500 (cg11391828)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.04E+00 Statistic Test p-value: 3.81E-02; Z-score: 1.83E+00

Methylation in Case

 9.21E-01 (Median) Methylation in Control 8.87E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in prostate cancer [ 2 ]

Location

 Body (cg15164708)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.55E+00 Statistic Test p-value: 7.62E-03; Z-score: 8.63E+00

Methylation in Case

 4.94E-01 (Median) Methylation in Control 3.19E-01 (Median)

Studied Phenotype

 Prostate cancer [ ICD-11: 2C82]

Experimental Material

 Patient tissue samples

  Bladder cancer

            6 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 TSS1500 (cg23338195)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -2.71E+00 Statistic Test p-value: 6.48E-11; Z-score: -1.43E+01

Methylation in Case

 2.83E-01 (Median) Methylation in Control 7.67E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 TSS200 (cg07459489)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.70E+00 Statistic Test p-value: 8.65E-09; Z-score: -2.06E+01

Methylation in Case

 5.19E-01 (Median) Methylation in Control 8.84E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 TSS200 (cg09439192)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.82E+00 Statistic Test p-value: 8.85E-09; Z-score: -8.15E+00

Methylation in Case

 4.18E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 TSS200 (cg07061355)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.38E+00 Statistic Test p-value: 8.86E-08; Z-score: -1.72E+01

Methylation in Case

 6.35E-01 (Median) Methylation in Control 8.74E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 Body (cg22342922)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.92E+00 Statistic Test p-value: 7.37E-10; Z-score: -2.35E+01

Methylation in Case

 4.33E-01 (Median) Methylation in Control 8.32E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC30A8 in bladder cancer [ 3 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.56E+00 Statistic Test p-value: 4.14E-06; Z-score: -6.84E+00

Methylation in Case

 4.44E-01 (Median) Methylation in Control 6.91E-01 (Median)

Studied Phenotype

 Bladder cancer [ ICD-11: 2C94]

Experimental Material

 Patient tissue samples

  Breast cancer

            5 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in breast cancer [ 4 ]

Location

 TSS1500 (cg23338195)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 1.87E-02; Z-score: -7.24E-01

Methylation in Case

 7.18E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in breast cancer [ 4 ]

Location

 TSS200 (cg07459489)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.22E+00 Statistic Test p-value: 5.32E-16; Z-score: 2.32E+00

Methylation in Case

 8.22E-01 (Median) Methylation in Control 6.73E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in breast cancer [ 4 ]

Location

 TSS200 (cg07061355)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.22E+00 Statistic Test p-value: 6.99E-16; Z-score: 2.38E+00

Methylation in Case

 7.73E-01 (Median) Methylation in Control 6.33E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC30A8 in breast cancer [ 4 ]

Location

 TSS200 (cg09439192)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.16E+00 Statistic Test p-value: 6.70E-09; Z-score: 1.23E+00

Methylation in Case

 6.53E-01 (Median) Methylation in Control 5.61E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC30A8 in breast cancer [ 4 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.11E+00 Statistic Test p-value: 1.68E-02; Z-score: 1.25E+00

Methylation in Case

 6.70E-01 (Median) Methylation in Control 6.02E-01 (Median)

Studied Phenotype

 Breast cancer [ ICD-11: 2C60-2C6Z]

Experimental Material

 Patient tissue samples

  Colorectal cancer

            7 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 TSS1500 (cg23338195)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.41E+00 Statistic Test p-value: 3.92E-12; Z-score: -3.31E+00

Methylation in Case

 5.15E-01 (Median) Methylation in Control 7.27E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 TSS200 (cg09439192)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.13E+00 Statistic Test p-value: 2.90E-09; Z-score: -4.20E+00

Methylation in Case

 7.41E-01 (Median) Methylation in Control 8.35E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 TSS200 (cg07459489)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 3.32E-09; Z-score: -5.19E+00

Methylation in Case

 8.57E-01 (Median) Methylation in Control 9.28E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 4

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 TSS200 (cg07061355)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.09E+00 Statistic Test p-value: 3.39E-08; Z-score: -5.21E+00

Methylation in Case

 8.50E-01 (Median) Methylation in Control 9.23E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 5

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 Body (cg22342922)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.12E+00 Statistic Test p-value: 4.21E-10; Z-score: -7.09E+00

Methylation in Case

 8.06E-01 (Median) Methylation in Control 8.99E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 6

 Methylation of SLC30A8 in colorectal cancer [ 5 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.16E+00 Statistic Test p-value: 1.49E-09; Z-score: -6.42E+00

Methylation in Case

 7.58E-01 (Median) Methylation in Control 8.77E-01 (Median)

Studied Phenotype

 Colorectal cancer [ ICD-11: 2B91]

Experimental Material

 Patient tissue samples

  HIV infection

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in HIV infection [ 6 ]

Location

 TSS1500 (cg23338195)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.08E+00 Statistic Test p-value: 1.22E-04; Z-score: -1.35E+00

Methylation in Case

 7.30E-01 (Median) Methylation in Control 7.88E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in HIV infection [ 6 ]

Location

 TSS200 (cg07061355)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.02E+00 Statistic Test p-value: 2.34E-03; Z-score: -7.37E-01

Methylation in Case

 8.94E-01 (Median) Methylation in Control 9.10E-01 (Median)

Studied Phenotype

 HIV infection [ ICD-11: 1C62.Z]

Experimental Material

 Patient tissue samples

  Lung adenocarcinoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in lung adenocarcinoma [ 7 ]

Location

 TSS200 (cg07061355)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.04E+00 Statistic Test p-value: 3.62E-02; Z-score: -1.74E+00

Methylation in Case

 8.22E-01 (Median) Methylation in Control 8.57E-01 (Median)

Studied Phenotype

 Lung adenocarcinoma [ ICD-11: 2C25.0]

Experimental Material

 Patient tissue samples

  Papillary thyroid cancer

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in papillary thyroid cancer [ 8 ]

Location

 TSS200 (cg07459489)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.00E+00 Statistic Test p-value: 3.21E-02; Z-score: -1.53E-01

Methylation in Case

 9.16E-01 (Median) Methylation in Control 9.19E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in papillary thyroid cancer [ 8 ]

Location

 Body (cg22342922)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.04E+00 Statistic Test p-value: 3.58E-03; Z-score: 9.99E-01

Methylation in Case

 8.93E-01 (Median) Methylation in Control 8.61E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in papillary thyroid cancer [ 8 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.11E+00 Statistic Test p-value: 4.19E-03; Z-score: 1.07E+00

Methylation in Case

 6.93E-01 (Median) Methylation in Control 6.25E-01 (Median)

Studied Phenotype

 Papillary thyroid cancer [ ICD-11: 2D10.1]

Experimental Material

 Patient tissue samples

  Systemic lupus erythematosus

            3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in systemic lupus erythematosus [ 9 ]

Location

 TSS200 (cg09439192)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.00E+00 Statistic Test p-value: 3.21E-02; Z-score: -5.29E-02

Methylation in Case

 8.21E-01 (Median) Methylation in Control 8.23E-01 (Median)

Studied Phenotype

 Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in systemic lupus erythematosus [ 9 ]

Location

 Body (cg22342922)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 3.33E-02; Z-score: -4.01E-01

Methylation in Case

 8.74E-01 (Median) Methylation in Control 8.85E-01 (Median)

Studied Phenotype

 Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 3

 Methylation of SLC30A8 in systemic lupus erythematosus [ 9 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.01E+00 Statistic Test p-value: 1.81E-02; Z-score: -2.82E-01

Methylation in Case

 8.61E-01 (Median) Methylation in Control 8.69E-01 (Median)

Studied Phenotype

 Systemic lupus erythematosus [ ICD-11: 4A40.0]

Experimental Material

 Patient tissue samples

  Hepatocellular carcinoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in hepatocellular carcinoma [ 10 ]

Location

 Body (cg03519481)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.23E+00 Statistic Test p-value: 7.36E-11; Z-score: -6.56E+00

Methylation in Case

 6.56E-01 (Median) Methylation in Control 8.10E-01 (Median)

Studied Phenotype

 Hepatocellular carcinoma [ ICD-11: 2C12.02]

Experimental Material

 Patient tissue samples

  Pancretic ductal adenocarcinoma

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in pancretic ductal adenocarcinoma [ 11 ]

Location

 Body (cg12461092)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.05E+00 Statistic Test p-value: 4.94E-03; Z-score: -6.88E-01

Methylation in Case

 6.16E-01 (Median) Methylation in Control 6.49E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in pancretic ductal adenocarcinoma [ 11 ]

Location

 Body (cg11072779)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.03E+00 Statistic Test p-value: 5.69E-03; Z-score: 8.97E-01

Methylation in Case

 8.54E-01 (Median) Methylation in Control 8.27E-01 (Median)

Studied Phenotype

 Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0]

Experimental Material

 Patient tissue samples

  Panic disorder

            2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in panic disorder [ 12 ]

Location

 Body (cg22342922)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.27E+00 Statistic Test p-value: 3.28E-03; Z-score: -3.51E-01

Methylation in Case

 6.95E-01 (Median) Methylation in Control 8.81E-01 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Epigenetic Phenomenon 2

 Methylation of SLC30A8 in panic disorder [ 12 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: 1.06E+00 Statistic Test p-value: 7.82E-04; Z-score: 4.32E-01

Methylation in Case

 2.64E+00 (Median) Methylation in Control 2.49E+00 (Median)

Studied Phenotype

 Panic disorder [ ICD-11: 6B01]

Experimental Material

 Patient tissue samples

  Atypical teratoid rhabdoid tumor

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Methylation of SLC30A8 in atypical teratoid rhabdoid tumor [ 13 ]

Location

 3'UTR (cg05548393)

Epigenetic Type

 Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

 Fold Change: -1.10E+00 Statistic Test p-value: 4.68E-14; Z-score: -2.57E+00

Methylation in Case

 8.13E-01 (Median) Methylation in Control 8.95E-01 (Median)

Studied Phenotype

 Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y]

Experimental Material

 Patient tissue samples

  Liver cancer

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant/significant hypermethylation of SLC30A8 in liver cancer than that in healthy individual/adjacent tissue

Studied Phenotype

 Liver cancer [ICD-11:2C12]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 9.62E-06; Fold-change: -0.547412976; Z-score: -1.453584842

The Methylation Level of Disease Section Compare with the Adjacent Tissue

 p-value: 2.71E-22; Fold-change: -0.534627587; Z-score: -11.04507417
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data of patients in the normal section of the tissue adjacent to the disease section
Download DT methylation data in the tissue of healthy individual
Download DT methylation data in the tissue of the other disease section

  Melanoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Moderate hypomethylation of SLC30A8 in melanoma than that in healthy individual

Studied Phenotype

 Melanoma [ICD-11:2C30]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 0.001665206; Fold-change: -0.234399479; Z-score: -3.633761527
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual

  Brain neuroblastoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant hypomethylation of SLC30A8 in brain neuroblastoma than that in healthy individual

Studied Phenotype

 Brain neuroblastoma [ICD-11:2A00.11]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 2.80E-18; Fold-change: -0.377935191; Z-score: -5.177968823
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual

  Esthesioneuroblastoma

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant hypomethylation of SLC30A8 in esthesioneuroblastoma than that in healthy individual

Studied Phenotype

 Esthesioneuroblastoma [ICD-11:2D50.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 1.65E-16; Fold-change: -0.586720142; Z-score: -7.122864438
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual

  Prostate cancer metastasis

            1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

 Significant hypomethylation of SLC30A8 in prostate cancer metastasis than that in healthy individual

Studied Phenotype

 Prostate cancer metastasis [ICD-11:2.00E+06]

The Methylation Level of Disease Section Compare with the Healthy Individual

 p-value: 0.003754991; Fold-change: -0.464723276; Z-score: -80.19237833
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples
Download DT methylation data of patients in the disease section of the tissue
Download DT methylation data in the tissue of healthy individual
References
1 Genetic, Epigenetic and Biological Effects of Zinc Transporter (SLC30A8) in Type 1 and Type 2 Diabetes. Curr Diabetes Rev. 2017;13(2):132-140.
2 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
3 DNA Methylation Dynamics in Urological Tumors.
4 Genome-wide Scan for Methylation Profiles in Breast Cancer
5 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
7 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
8 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
9 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
10 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
11 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
12 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
13 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.